Evaluating maternal serum sortilin levels: a potential biomarker for predicting preeclampsia
Our findings indicate that maternal sortilin levels are elevated in patients with preeclampsia compared to those in a healthy pregnant control group. Furthermore, maternal sortilin levels may predict adverse neonatal outcomes. In addition, sortilin levels are correlated key clinical markers of preeclampsia severity.
Authors
- Ali Turhan Çağlar (ORCID: https://orcid.org/0000-0002-7022-3029)
- Nazan Vanlı Tonyalı (ORCID: https://orcid.org/0000-0002-7284-6887)
- Betül Tokgöz Çakır (ORCID: https://orcid.org/0000-0003-0202-4981)
- Burak Bayraktar (ORCID: https://orcid.org/0000-0001-6233-4207)
- Zeynep Şeyhanlı (ORCID: https://orcid.org/0000-0003-3924-3723)
- Gülşan Karabay (ORCID: https://orcid.org/0000-0003-2567-2850)
- Serap Topkara Sucu (ORCID: https://orcid.org/0000-0002-9187-2941)
- Gizem Aktemur (ORCID: https://orcid.org/0000-0001-6824-881X)
- Dilara Kurt (ORCID: https://orcid.org/0000-0002-1492-0305)
- Umut Karabay (ORCID: https://orcid.org/0000-0002-9632-360X)
Institutions
- Gülhane Askerî Tıp Akademisi (TR)
- Memorial Ankara Hospital (TR)
Publication Details
- Journal
- BMC Pregnancy and Childbirth
- Published
- 2025-03-25
- DOI
- https://doi.org/10.1186/s12884-025-07452-z
- Citations
- 1
- Primary Topic
- Pregnancy and preeclampsia studies
- Type
- article
- Field-Weighted Citation Impact
- 2.06